References
- Fitzhugh CD, Hsieh MM, Bolan CD, Saenz C, Tisdale JF. Granulocyte colony-stimulating factor (G-CFS) administration in individuals with sickle cell disease: time for a moratorium? Cytotherapy 2009; 11:464–71.
- LeBlanc R, Roy J, Demers C, Cantin G. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors. Bone Marrow Transplant 1999; 23:991–6.
- Topçuoğlu P, Arat M, Dalva K, Ozcan M. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors. Bone Marrow Transplant 2004; 33:171–6.
- Kaptan K, Ifran A, Beyan C, Sertkaya D. Recombinant human granulocyte colony-stimulating factor (rhG-CSF) promotes in vitro platelet aggregation. Hematology 2007; 12:441–4.
- Conti JA, Scher HI. Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor. A possible new recombinant granulocyte colony-stimulating factor toxicity. Cancer 1992; 70:2699–702.
- Lindemann A, Rumberger B. Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF). Eur J Cancer 1993; 29A:2338–9.
- Anderlini P, Korbling M, Dale D, Gratwohl A, Schmitz N, Stroncek D, . Allogeneic blood stem cell transplantation: considerations for donors. Blood 1997; 90:903–8.